# Neuropediatrics

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/neuropediatrics/

## Facts

| Field | Value |
| --- | --- |
| Citations | 79,891 |
| h-index | 100 |
| Homepage | https://www.thieme.in/neuropediatrics |
| Open Access | false |
| ISSN-L | 0174-304X |
| ISSNs | 0174-304X,1439-1899 |
| OpenAlex ID | https://openalex.org/S44923075 |
| Publisher | Thieme Medical Publishers (Germany) |
| Works | 7,746 |

## Journal papers

- [Earliest Clinical Manifestations and Natural History of Neurofibromatosis Type 2 (NF2) in Childhood: A Study of 24 Patients](https://scholariq.org/papers/earliest-clinical-manifestations-and-natural-history-of-neurofibromatosis-type-2/)
- [Limited Knowledge of Tourette Syndrome Causes Delay in Diagnosis](https://scholariq.org/papers/limited-knowledge-of-tourette-syndrome-causes-delay-in-diagnosis/)
- [Effects of Oral Creatine Supplementation in a Patient with MELAS Phenotype and Associated Nephropathy](https://scholariq.org/papers/effects-of-oral-creatine-supplementation-in-a-patient-with-melas-phenotype-and/)
- [Chilblains as a Diagnostic Sign of Aicardi-Goutières Syndrome](https://scholariq.org/papers/chilblains-as-a-diagnostic-sign-of-aicardi-goutieres-syndrome/)
- [Novel MECR Mutation in Childhood-Onset Dystonia, Optic Atrophy, and Basal Ganglia Signal Abnormalities](https://scholariq.org/papers/novel-mecr-mutation-in-childhood-onset-dystonia-optic-atrophy-and-basal-ganglia/)
- [Fenfluramine Treatment Improves Everyday Executive Functioning in Patients with Lennox-Gastaut Syndrome: Analysis from a Phase 3 Clinical Trial](https://scholariq.org/papers/fenfluramine-treatment-improves-everyday-executive-functioning-in-patients-with/)
- [Decreased Cognitive Function in Danish Children with Epilepsy](https://scholariq.org/papers/decreased-cognitive-function-in-danish-children-with-epilepsy/)
- [Fenfluramine Increases Seizure-Free Days in Patients With Lennox–Gastaut Syndrome](https://scholariq.org/papers/fenfluramine-increases-seizure-free-days-in-patients-with-lennox-gastaut/)
- [Long-Term Comparative Efficacy and Safety of Risdiplam versus Nusinersen in Children with Type 1 Spinal Muscular Atrophy (SMA)](https://scholariq.org/papers/long-term-comparative-efficacy-and-safety-of-risdiplam-versus-nusinersen-in/)

## Journal top topics

Showing 8 of 25.

- [Metabolism and Genetic Disorders](https://scholariq.org/topics/metabolism-and-genetic-disorders/)
- [Epilepsy research and treatment](https://scholariq.org/topics/epilepsy-research-and-treatment/)
- [Neonatal and fetal brain pathology](https://scholariq.org/topics/neonatal-and-fetal-brain-pathology/)
- [Mitochondrial Function and Pathology](https://scholariq.org/topics/mitochondrial-function-and-pathology/)
- [Fetal and Pediatric Neurological Disorders](https://scholariq.org/topics/fetal-and-pediatric-neurological-disorders/)
- [Genetics and Neurodevelopmental Disorders](https://scholariq.org/topics/genetics-and-neurodevelopmental-disorders/)
- [Cerebral Palsy and Movement Disorders](https://scholariq.org/topics/cerebral-palsy-and-movement-disorders/)
- [Pharmacological Effects and Toxicity Studies](https://scholariq.org/topics/pharmacological-effects-and-toxicity-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
